Third-Generation Bisphosphonates for Treatment of Sensorineural Hearing Loss in Otosclerosis
Otology and Neurotology - United States
doi 10.1097/mao.0b013e318268d1b3
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2012
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)